ConductScience.org, home

Paper41544

Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients.

Heffron WA and 1 other. Br J Clin Pharmacol, 1979. Cited by 24 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients. Papers, record 41544. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41544

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Double-blind evaluation of the safety and hypnotic efficacy of temazepam in insomniac outpatients.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
24
iCite
Relative citation ratio, by iCite
2.01
iCite
Revised in PubMed
2019-05-09
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Heffron WAW A
2Roth PP

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anti-Anxiety AgentsMajor topic
Sleep Initiation and Maintenance DisordersMajor topic
TemazepamMajor topic
Clinical Trials as Topic
Double-Blind Method
Female
Humans
Male
Placebos
Sleep
Time Factors

Source PubMed

Cited by8

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 24 citations.

PMIDTitleJournalYearIn PapersSource
41,756,263
A pilot, parallel-group, blinded, placebo-controlled, randomiseD, pRagmatic clinical trial investigating the Effect of temazepAM on objective and subjective measures of sleep in critically ill patients (the DREAM trial).
Crit Care Resusc2026https://conductscience.org/library/papers/41756263PubMed
27,998,379Clinical Practice Guideline for the Pharmacologic Treatment of Chronic Insomnia in Adults: An American Academy of Sleep Medicine Clinical Practice Guideline.J Clin Sleep Med2017https://conductscience.org/library/papers/27998379PubMed
10,674,059Meta-analysis of benzodiazepine use in the treatment of insomnia.CMAJ2000https://conductscience.org/library/papers/10674059PubMed
6,146,327Temazepam's efficacy in patients with sleep onset insomnia.Br J Clin Pharmacol1984https://conductscience.org/library/papers/6146327PubMed
6,146,153Psycho-social stress, insomnia and temazepam: a sleep laboratory evaluation in a "general practice" sample.Psychopharmacology (Berl)1984https://conductscience.org/library/papers/6146153PubMed
6,133,538The use of short- and long-acting hypnotics in clinical medicine.Br J Clin Pharmacol1981https://conductscience.org/library/papers/6133538PubMed
6,112,127Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic.Drugs1981https://conductscience.org/library/papers/6112127PubMed
2,891,534Pharmacokinetics of temazepam after day-time and night-time oral administration.Eur J Clin Pharmacol1987https://conductscience.org/library/papers/2891534PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41544

GET https://conductscience.org/api/papers/v1/41544/authors